BofA Securities analyst Jason Gerberry maintains $Alkermes (ALKS.US)$ with a hold rating.
According to TipRanks data, the analyst has a success rate of 46.6% and a total average return of 1.9% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Alkermes (ALKS.US)$'s main analysts recently are as follows:
Alkermes has delivered a Q3 performance that aligns with forecasts while maintaining guidance for 2024. The primary attention during the earnings discussion centered around projections that 2025 EBITDA will exceed $200M, contrasting with a general expectation of $400M. This discrepancy in EBITDA relative to market projections seems to be influenced by the diminishing of high-margin royalty revenues, and to a smaller degree, elevated expenditure.
Alkermes' Q3 results exhibited a mix of positive and negative aspects, yet overall aligned with expectations based on the current commercial portfolio. The company is demonstrating a commitment to intensify and concentrate investments in ALKS-2680, along with harnessing the broad possibilities presented by its orexin-2 receptor agonist pipeline. Despite the near-term effects moderating profit levels, the prospects for value generation from ALKS-2680 remain promising.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
